RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-18.69%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$714M
AUM Growth
+$714M
(-22%)
Cap. Flow
-$1.38M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
30.92%
Holding
97
New
3
Increased
39
Reduced
32
Closed
12
Top Buys
| 1 |
AbbVie
ABBV
|
$9.14M |
| 2 |
Zimmer Biomet
ZBH
|
$8.09M |
| 3 |
CVS Health
CVS
|
$7.11M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.66M |
| 5 |
UnitedHealth
UNH
|
$5.49M |
Top Sells
| 1 |
DERM
Dermira, Inc.
DERM
|
$12.1M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$10.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$10.1M |
| 4 |
Humana
HUM
|
$6.91M |
| 5 |
Becton Dickinson
BDX
|
$4.6M |
Sector Composition
| 1 | Healthcare | 96.22% |
| 2 | Energy | 0.06% |
| 3 | Technology | 0.03% |
| 4 | Financials | 0.02% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Iovance Biotherapeutics
IOVA
$800M
| $10.9M | 1.53% |
365,000
-110,000
| -23% | -$3.29M |
|
27
Edwards Lifesciences
EW
$47.7B
| $10.8M | 1.51% |
57,000
+19,000
| +50% | +$3.58M |
|
28
Centene
CNC
$14.8B
| $10.4M | 1.46% |
175,000
+35,000
| +25% | +$2.08M |
|
|
ARNA
29
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $10.1M | 1.41% |
240,000
+20,000
| +9% | +$840K |
|
|
MRTX
30
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.99M | 1.4% |
130,000
+5,000
| +4% | +$384K |
|
|
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.81M | 1.37% |
85,000
-35,000
| -29% | -$4.04M |
|
|
AERI
32
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $9.72M | 1.36% |
720,000
+20,000
| +3% | +$270K |
|
33
Xencor
XNCR
$594M
| $8.97M | 1.26% |
300,325
-9,675
| -3% | -$289K |
|
|
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.72M | 1.22% |
567,534
+67,534
| +14% | +$1.04M |
|
35
Alnylam Pharmaceuticals
ALNY
$58.6B
| $8.71M | 1.22% |
80,000
+19,285
| +32% | +$2.1M |
|
36
FibroGen
FGEN
$48.4M
| $8.69M | 1.22% |
250,000
-25,000
| -9% | -$869K |
|
37
LivaNova
LIVN
$3.09B
| $8.6M | 1.2% |
190,000
-10,000
| -5% | -$453K |
|
|
MYOK
38
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.44M | 1.18% |
180,000
-30,000
| -14% | -$1.41M |
|
39
HCA Healthcare
HCA
$95.4B
| $8.09M | 1.13% |
90,000
+20,000
| +29% | +$1.8M |
|
|
40
Zimmer Biomet
ZBH
$20.8B
| $8.09M | 1.13% |
+80,000
| New | +$8.09M |
|
|
IMMU
41
DELISTED
Immunomedics Inc
IMMU
| $7.95M | 1.11% |
590,000
-110,000
| -16% | -$1.48M |
|
42
Biogen
BIIB
$20.8B
| $7.91M | 1.11% |
25,000
+5,000
| +25% | +$1.58M |
|
43
Cooper Companies
COO
$13.3B
| $6.62M | 0.93% |
24,000
+4,000
| +20% | +$1.1M |
|
|
XLRN
44
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.29M | 0.88% |
70,000
-30,000
| -30% | -$2.7M |
|
45
Exact Sciences
EXAS
$9.33B
| $6.05M | 0.85% |
104,300
-2,700
| -3% | -$157K |
|
46
MacroGenics
MGNX
$121M
| $5.82M | 0.82% |
1,000,000
-60,000
| -6% | -$349K |
|
47
Alkermes
ALKS
$4.95B
| $5.75M | 0.81% |
399,000
+29,000
| +8% | +$418K |
|
48
Omnicell
OMCL
$1.51B
| $5.65M | 0.79% |
86,095
-8,905
| -9% | -$584K |
|
|
SILK
49
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $5.51M | 0.77% |
175,000
-34,381
| -16% | -$1.08M |
|
|
EPZM
50
DELISTED
Epizyme, Inc
EPZM
| $5.43M | 0.76% |
350,000
-75,000
| -18% | -$1.16M |
|